Back to results
CompletedPhase 1

Drug Interaction Study With a Potential Alzheimer's Disease Compound

NCT00726726

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Bristol-Myers Squibb Clinical Pharmacology Unit

Hamilton, New Jersey, United States

View on ClinicalTrials.gov
Drug Interaction Study With a Potential Alzheimer's Disease Compound — TrialFind